Abstract
Background Pneumonia, an infection of the lung parenchyma, is classified into community-acquired pneumonia (CAP) and nosocomial pneumonia. CAP occurs in patients who have not been hospitalized or resided in long-term care facilities for more than 14 days before symptom onset. Diabetes mellitus (DM), an immunosuppressive condition, predisposes patients to severe infections, including pneumonia. Diabetic patients with CAP often encounter more virulent or atypical pathogens and show increased resistance to conventional antibiotics. This study aimed to identify the bacterial etiology of CAP in diabetic patients and assess their antibiotic sensitivity patterns.
Methods
A descriptive cross-sectional study was conducted in the Department of Medicine, Shaheed Suhrawardy Medical College Hospital, Dhaka, from 29th December 2017 to 28th June 2018. A total of 100 diabetic patients with CAP were enrolled following a structured protocol that included history-taking, clinical examination, and relevant investigations. Sputum samples were analyzed using standard microbiological techniques. Data were processed and analyzed using SPSS version 22 and Microsoft Excel. Quantitative data were expressed as mean ± standard deviation, while qualitative data were presented as frequency and percentage.
Results
The majority of the patients (54%) were between 51–60 years, with a mean age of 49.7 ± 9.23 years. Of the 100 cases, 62% were male, and 38% were female, with a male-to-female ratio of 1.6:1. High-grade fever, sweating, and cough were the most common symptoms. Sputum cultures revealed growth in 92% of samples. The predominant pathogens were Klebsiella pneumoniae (30.4%), Streptococcus pneumoniae (23.9%), and Staphylococcus aureus (13.0%). Antibiotic resistance was highest against ceftriaxone and amoxicillin, with variable sensitivity across isolates.
Conclusion
The study concludes that poor glycemic control is associated with increased susceptibility to infections. Early detection, appropriate management, and strict glycemic control can reduce the burden of pneumonia in diabetic patients.
Understanding the Relationship Between Pneumonia and Diabetes Pneumonia is a serious lung infection causing coughing, fever, and breathing difficulties. People with diabetes are more vulnerable to infections due to weakened immune systems. This study, conducted in Bangladesh, explores how diabetes affects the bacteria causing pneumonia and their resistance to antibiotics.
Key Findings
The most common bacteria in diabetic pneumonia patients were Klebsiella pneumoniae (30.4%), Streptococcus pneumoniae (23.9%), and Staphylococcus aureus (13.0%).
Antibiotics that lost efficacy due to resistance were highest for ceftriaxone and amoxicillin.
Poor blood sugar control led to more infections and antibiotic resistance.
Why It Matters These findings highlight the need for strict blood sugar control and careful antibiotic selection to reduce pneumonia risks in diabetic patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from the Ethics Committee of Shaheed Suhrawardy Medical College Hospital, Dhaka, Bangladesh before commencing the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.